Sacubitril-Valsartan Improves Anemia Of Cardiorenal Syndrome.
CONCLUSIONS: Sacubitril-valsartan improves anemia in CRS patients. An improvement of serum cystatin levels was observed. Few untoward effects were detected. These findings should be confirmed in wider clinical trials.
PMID: 32370725 [PubMed - as supplied by publisher]
Source: Cardiovascular and Hematological Agents in Medicinal Chemistry - Category: Cardiology Tags: Cardiovasc Hematol Agents Med Chem Source Type: research
More News: Anemia | Cardiology | Cardiovascular | Chemistry | Chronic Kidney Disease | Clinical Trials | Diovan | Heart | Heart Failure | Hematology | Study | Urology & Nephrology